MSA
LMAT icon

Marino Stram & Associates’s LeMaitre Vascular LMAT Stock Holding History

Marino Stram & Associates’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-141
Closed -$4K – 353
2019
Q1 		$4K Sell
141
-11
-7% -$294 ﹤0.01% 417
2018
Q4 		$4K Buy
+152
New +$4.15K ﹤0.01% 365

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Marino Stram & Associates's LMAT Position: Q2 2019 in Review

Marino Stram & Associates sold out of LeMaitre Vascular (LMAT) in Q2 2019, closing a stake of 141 shares — an estimated $4K sold.

Marino Stram & Associates first reported a position in LMAT in Q4 2018 and held it in 2 quarters. The position peaked at $4K in Q1 2019. 150 funds tracked by Wall St. Rank hold LMAT as of Q2 2019.

  • Marino Stram & Associates reported no remaining LeMaitre Vascular position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 141 LeMaitre Vascular shares in Q2 2019, an estimated $4K.
  • Marino Stram & Associates first reported a position in LeMaitre Vascular in Q4 2018 and held it in 2 quarters.
  • Marino Stram & Associates's LeMaitre Vascular position peaked at $4K in Q1 2019.
  • 150 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.